OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
January 02, 2012
A Q&A with Gilles Cottier, president of SAFC, on recent industry trends.
December 02, 2011
Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals.
A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Cleanliness is crucial, even if zapping and trapping is necessary to reduce product contamination.
Added responsibilities and outside concerns prompt overhaul of agency's structure.
Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry.
Packaging is indeed headed to be a lead sector in the Asian pharmaceutical environment, but certain challenges must first be overcome.
A Q&A with Deborah Tanner, executive vice-president and group president of R&D laboratories at Covance, on recent industry trends.
Readers react to the economic turmoil of the past year and look longingly forward to 2012.
November 02, 2011
Small drug companies with hopes of achieving $1 billion in sales can pursue various strategies.